| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6201316 | Ophthalmology | 2014 | 8 Pages |
Abstract
At week 52, IAI demonstrated significant superiority in functional and anatomic endpoints over laser, with similar efficacy in the 2q4 and 2q8 groups despite the extended dosing interval in the 2q8 group. In general, IAI was well-tolerated.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Jean-François MD, Diana V. MD, Ursula MD, David S. MD, Frank G. MD, Jeffrey S. MD, Edoardo MD, Peter K. MD, Hiroko MD, Dennis M. MD, Quan D. MD, Glenn J. MD, Jason S. MD, Christian MD, Yuhwen PhD, Thomas PhD, George D. MD, PhD, Neil PhD, David M. MD,